Yi-Ching Wang - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Yi-Ching Wang's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Yi-Ching Wang

Yi-Ching Wang

Verified

Associate Editor, Journal of Biomedical Science

Taiwan

Final Covers

resilience success, Mindfulness, leadership influence, complexity, Society, well doing responsibility, Wellbeing, Motivation

Doesn’t Cover

Tech.

Journalist Type

Seniority Positions

Industries

-

Content

Total articles 9

  • Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma - Journal of Biomedical Science

    By Chih-Hsiung Hsieh, Wen-Lun Wang, Fu-Hsuan Shih, Pei-Wen Wang, Dar-Bin Shieh, Wei-Lun Chang, Yi-Ching Wang, Pei-Shiuan Ho, Chen-Tai Hong| Journal of Biomedical Science Verified Taiwanese ESCC cell lines CE81T and CE48T were obtained from Dr. Han-Suei Hsu (Division of Thoracic Surgery, Taipei Veterans General Hospital, Taiwan). Japanese ESCC cell line, KYSE510, was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures (Braunschweig, Lower Saxony, Germany), where they were characterized by DNA-fingerprinting and isozyme detection.

    By Chih-Hsiung Hsieh, Wen-Lun Wang, Fu-Hsuan Shih, Pei-Wen Wang, Dar-Bin Shieh, Wei-Lun Chang, Yi-Ching Wang, Pei-Shiuan Ho, Chen-Tai Hong · Journal of Biomedical Science

    Sep. 11, 2024

  • Utilizing adeno‐associated virus as a vector in treating genetic disorders or human cancers

    By Yi-Ching Wang, Fu-Hsuan Shih, Hsiung-Hao Chang| Wiley Online Library Verified CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest with the contents of this article. REFERENCES 1, , , , , , et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74: 229–263. 2. Epidemiology of cancer. Clin Chem. 2024; 70: 140–149. 3, , , , . Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics. 2021; 11: 6370–6392. 4, , , , , , et al.

    By Yi-Ching Wang, Fu-Hsuan Shih, Hsiung-Hao Chang · Wiley Online Library

    Jul. 06, 2024

  • Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma - Journal of Biomedical Science

    By Chih-Hsiung Hsieh, Wen-Lun Wang, Fu-Hsuan Shih, Pei-Wen Wang, Dar-Bin Shieh, Wei-Lun Chang, Yi-Ching Wang, Pei-Shiuan Ho, Chen-Tai Hong| Journal of Biomedical Science Verified Taiwanese ESCC cell lines CE81T and CE48T were obtained from Dr. Han-Suei Hsu (Division of Thoracic Surgery, Taipei Veterans General Hospital, Taiwan). Japanese ESCC cell line, KYSE510, was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures (Braunschweig, Lower Saxony, Germany), where they were characterized by DNA-fingerprinting and isozyme detection.

    By Chih-Hsiung Hsieh, Wen-Lun Wang, Fu-Hsuan Shih, Pei-Wen Wang, Dar-Bin Shieh, Wei-Lun Chang, Yi-Ching Wang, Pei-Shiuan Ho, Chen-Tai Hong · Journal of Biomedical Science

    Sep. 11, 2024

As seen in

Company Info

Journal of Biomedical Science